Company Search:
Advanced Search
Sponsored Links
Emblem Corp Company Snapshot
Emblem Corp operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Emblem Corp with three other pharmaceutical manufacturers in North America: AmpliPhi Biosciences Corp of the United States (2016 sales of $260,000.00 ), CytRx Corporation of the United States ($200,000.00 of which 100% was Pharmaceutical Product Developers), and CEL-SCI Corporation which is also based in the United States ($285,055.00 of which 100% was Pharmaceutical Products).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Emblem Corp
  Stock Performance Chart for Emblem Corp
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 1.54
(Figures in Canadian Dollars)
1 Week 0.0%   13 Weeks 6.9%  
4 Weeks -27.7%   52 Weeks -46.2%  
Emblem Corp Key Data:
  Ticker: EMC Country: Canada
  Exchanges: VEN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 276,907
(Year Ending Jan 2017).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 110,263,971
  Fiscal Yr Ends: December Shares Outstanding: 71,599,981
  Share Type: Common Closely Held Shares: 12,842,883
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.